Clinical Trial Update: Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and effectiveness of the PXL-Platinum 330 System for corneal cross-linking is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Keratitis
• Corneal Ectasia
• Keratoconus

Drugs mentioned

• PXL Platinum 330 System

Snippet

Sponsor: Pacific Clear Vision Institute | Conditions: Keratoconus, Unstable, Bacterial Keratitis | Phase 1 | Status: RECRUITING